Medicare Part D
-
340B, Biosimilars, Caught my eye, CMMI, Medicare Advantage, Medicare Part D, Obesity, Pharmacy Benefit ManagersCaught my eye — 3/14/25
Read more: Caught my eye — 3/14/25With the exception of the ending of demos/models at the Centers for Medicare & Medicaid Innovation (CMMI), most of the news kind of rolled over me this week. So, instead, here is a capture of what is rattling around my chamber of health policy worries. Who’s on first? What’s on second? I don’t know ……
-
Caught my eye, Generics, Healthcare Costs, ICER, Inflation Reduction Act, Medicaid, Medicare Negotiation, Medicare Part D, Orphan Drugs, State-based Reform, ValueCaught my eye — 03/07/25
Read more: Caught my eye — 03/07/25Tuesday morning, I spent the first half of the day convinced it was Wednesday, and yet, despite that mental setback, the rest of the week has flown by. Feels like a win. Killing me softly. Overall, glad to see the stories recognizing how the uncertainty of federal research dollars is impacting NIH summer internships, graduate…
-
Caught my eye, Healthcare Costs, ICER, Inflation Reduction Act, Medicare Negotiation, Medicare Part D, Obesity, ValueCaught my eye — 2/14/25
Read more: Caught my eye — 2/14/25Roses are red. Violets are blue. I love health policy, how about you? Public Health Gap: This week a poll found that a quarter of Americans see healthcare access and affordability as their top public health concern and think it would be best solved on the federal level. Among Democrats, 32% had it as their…
-
Affordable Care Act, Caught my eye, Cell and Gene, CMMI, Medicare Negotiation, Medicare Part D, Medicare Transaction Facilitator, Pharmacy Benefit ManagersCaught my eye — 2/7/25
Read more: Caught my eye — 2/7/25In the DC area, with many family, friends and neighbors working for the federal government, these last few weeks have felt downright crappy. Furloughs, contracts being upended, fear about what’s next — all for people who love their jobs serving the public. It isn’t a fork in the road, it feels like a game of…
-
Caught my eye — 1/24/25
Read more: Caught my eye — 1/24/25I am pretty sure January is actually the whole first half of the year. Bears and hibernation might have the right idea. Old Hat Already: I hit send last week and the Centers for Medicare & Medicaid Services (CMS) released the list of 2027 Medicare negotiated drugs. Overall it felt like just another announcement with…
-
340B, Caught my eye, Inflation Reduction Act, Medicare Negotiation, Medicare Part D, Pharmacy Benefit ManagersCaught my eye — 1/16/25
Read more: Caught my eye — 1/16/25Tell me a Story. If you’ve been reading my stuff for a while, you know that I love a good lawsuit filing. Sometimes the lawyers get a little spicy. Teva filed suit against the federal government for the Inflation Reduction Act and it has a few gems: The suit is different from others that have…
-
340B, Caught my eye, Drug Prices, Healthcare Costs, Inflation Reduction Act, Medicare Negotiation, Medicare Part D, Pharmacy Benefit ManagersCaught my eye — 1/10/25
Read more: Caught my eye — 1/10/25There are some weeks where your long-term success could be impacted if you’re not on top of what’s happening, this isn’t one of those weeks. But these things are cumulative so, if need help on the regular with strategy and health policy (like figuring out what you need to pay attention to, help understanding the…
-
Caught my eye — 12/20/24
Read more: Caught my eye — 12/20/24Is anybody out there? It seems like everyone has disappeared for the rest of the year. And who can blame them? A few odds and ends caught my eye as I got ready to wrap up this year… Rebatable: 2025 should be interesting with now 4 companies pursuing the rebate model and suing the government.…
-
Caught my eye, Drug Prices, Healthcare Costs, Inflation Reduction Act, Medicare Negotiation, Medicare Part DCaught my eye — 11/22/24
Read more: Caught my eye — 11/22/24As we look ahead to next week and Thanksgiving, I have to say thank you to you for subscribing and reading. I got the stuffing knocked out of me this summer but knowing that this group of subscribers hangs in there and continues to read is nice. As I look ahead to the next year,…
-
Caught my eye — 11/8/24
Read more: Caught my eye — 11/8/24Some days you eat the bear and some days the bear eats you. Looking at Canada? No, not like that. JAMA featured a supply chain shortage look at the U.S. versus Canada. While not all of the lessons from Canada carry over (more flat bureaucracy because of connections between regulators and facilities) – they do…
Latest news
- Caught my eye — 03/28/25
- Caught my eye — 3/21/25
- Caught my eye — 3/14/25
- Caught my eye — 03/07/25
- Caught my eye — 2/28/25
Categories
- 340B (33)
- Affordable Care Act (4)
- Alzheimer's (5)
- Biosimilars (20)
- Caught my eye (61)
- Cell and Gene (1)
- Chevron Deference (2)
- CMMI (10)
- Copay Accumulators (6)
- COVID (2)
- Drug Prices (30)
- Drug shortages (8)
- DTC (2)
- Employers (7)
- Generics (5)
- Health Equity (3)
- Healthcare Costs (28)
- ICER (9)
- Importation (2)
- Inflation Reduction Act (45)
- Insulin (4)
- IP (3)
- Long term care (1)
- Medicaid (6)
- Medicare Advantage (15)
- Medicare Negotiation (48)
- Medicare Part D (44)
- Medicare Transaction Facilitator (2)
- Medicare Transaction Facilitator (7)
- Obesity (20)
- On the Horizon (1)
- Orphan Drugs (3)
- Pharmacy Benefit Managers (28)
- Reference Pricing (5)
- State-based Reform (14)
- Supply Chain (1)
- Uncategorized (4)
- Utilization Management (1)
- Vaccines (4)
- Value (12)